Dev Prasad

Stock Analyst at LUCID CAPITAL MARKETS

(1.49)

# 3,258

Out of 4,740 analysts

3

Total ratings

66.67%

Success rate

-2.73%

Average return

Main Sectors:

Top Industries:

Stocks Rated by Dev Prasad

	Stock	Action	Price Target	Current	Upside	Ratings	Updated
	AVTX Avalo Therapeutics	Initiates: Buy	$24	$6.59	+264.19%	1	Dec 17, 2024
	IBIO iBio, Inc.	Initiates: Buy	$6	$3.07	+95.44%	1	Dec 17, 2024
	CALC CalciMedica	Initiates: Buy	$13	$2.94	+342.18%	1	Dec 17, 2024

Avalo Therapeutics

Dec 17, 2024

Initiates: Buy

Price Target: $24

Current: $6.59

Upside: +264.19%

iBio, Inc.

Dec 17, 2024

Initiates: Buy

Price Target: $6

Current: $3.07

Upside: +95.44%

CalciMedica

Dec 17, 2024

Initiates: Buy

Price Target: $13

Current: $2.94

Upside: +342.18%